Medicines Act Notices




13 MARCH 2014 NEW ZEALAND GAZETTE, No. 29 825

The appointment of the above-named person takes effect on the date this notice is published in the New Zealand Gazette and ends on 24 March 2017.

Dated at Wellington this 25th day of February 2014.

CHAI CHUAH, Acting Director-General of Health.

go1322

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Apo-Zoledronic Acid
Active Ingredient: Zoledronic acid monohydrate 0.853mg/mL equivalent to Zoledronic acid 0.80mg/ml
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Agila Specialties Polska Sp. z.o.o, Warsaw, Poland

Product: Aripiprazole generichealth
Active Ingredient: Aripiprazole 5mg
Dosage Form: Tablet
New Zealand Sponsor: CARSL Consulting
Manufacturer: Indoco Remedies Limited, Goa, India

Product: Aripiprazole generichealth
Active Ingredient: Aripiprazole 10mg
Dosage Form: Tablet
New Zealand Sponsor: CARSL Consulting
Manufacturer: Indoco Remedies Limited, Goa, India

Product: Aripiprazole generichealth
Active Ingredient: Aripiprazole 15mg
Dosage Form: Tablet
New Zealand Sponsor: CARSL Consulting
Manufacturer: Indoco Remedies Limited, Goa, India

Product: Aripiprazole generichealth
Active Ingredient: Aripiprazole 20mg
Dosage Form: Tablet
New Zealand Sponsor: CARSL Consulting
Manufacturer: Indoco Remedies Limited, Goa, India

Product: Aripiprazole generichealth
Active Ingredient: Aripiprazole 30mg
Dosage Form: Tablet
New Zealand Sponsor: CARSL Consulting
Manufacturer: Indoco Remedies Limited, Goa, India

Product: Capercit
Active Ingredient: Capecitabine 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Dr Reddy’s Laboratories Limited, Andhra Pradesh, India

Product: Capercit
Active Ingredient: Capecitabine 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Dr Reddy’s Laboratories Limited, Andhra Pradesh, India

Product: Lyxumia
Active Ingredient: Lixisenatide 0.05mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 29





✨ LLM interpretation of page content

🏥 Appointment of Compulsory Care Co-ordinator (continued from previous page)

🏥 Health & Social Welfare
25 February 2014
Intellectual Disability, Compulsory Care Co-ordinator, Appointment
  • Chai Chuah, Acting Director-General of Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines, Distribution, Consent, New Zealand